William Hoffman - Apr 5, 2022 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
President and CEO, Director
Signature
/s/ Angela Ahmad, attorney-in-fact for
Stock symbol
NARI
Transactions as of
Apr 5, 2022
Transactions value $
-$2,707,626
Form type
4
Date filed
4/7/2022, 04:34 PM
Previous filing
Apr 5, 2022
Next filing
May 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $12.8K +30K +5.45% $0.43* 580K Apr 5, 2022 Direct F1
transaction NARI Common Stock Sale -$246K -2.77K -0.48% $88.78 578K Apr 5, 2022 Direct F1, F2
transaction NARI Common Stock Sale -$642K -7.15K -1.24% $89.77 570K Apr 5, 2022 Direct F1, F3
transaction NARI Common Stock Sale -$1.82M -20.1K -3.52% $90.63 550K Apr 5, 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Options (Right to buy) Options Exercise -$12.8K -30K -17.6% $0.43* 140K Apr 5, 2022 Common Stock 30K $0.43 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $88.20 to $89.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $89.22 to $90.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $90.22 to $91.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 Option vested with respect to 25% of the underline shares on May 3, 2019 and vest with respect to the remaining shares in 36 equal monthly installments thereafter.